Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease-Reference-Cited by-同舟云学术

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

Published:2019-03-21 Issue:1 Volume:11 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Startin Carla M.^ORCID, ,Ashton Nicholas J.,Hamburg Sarah,Hithersay Rosalyn,Wiseman Frances K.,Mok Kin Y.,Hardy John,Lleó Alberto,Lovestone Simon,Parnetti Lucilla,Zetterberg Henrik,Hye Abdul,Strydom André

Funder

Wellcome Trust

UCL ARUK network

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-019-0477-0.pdf

Reference76 articles.

1. Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat Rev Neurosci. 2015;16:564–74.

2. McCarron M, McCallion P, Reilly E, Mulryan N. A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome. J Intellect Disabil Res. 2014;58:61–70.

3. Sinai A, Mokrysz C, Bernal J, Bohnen I, Bonell S, Courtenay K, Dodd K, Gazizova D, Hassiotis A, Hillier R, et al. Predictors of age of diagnosis and survival of Alzheimer’s disease in Down syndrome. J Alzheimers Dis. 2018;61:717–28.

4. Hithersay R, Startin CM, Hamburg S, Mok KY, Hardy J, Fisher EMC, Tybulewicz VLJ, Nizetic D, Strydom A. Association of dementia with mortality among adults with Down syndrome older than 35 years. JAMA Neurol. 2019;76:152–60.

5. Wu J, Morris JK. The population prevalence of Down’s syndrome in England and Wales in 2011. Eur J Hum Genet. 2013;21:1016–9.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practicalities (and real‐life experiences) of dementia in adults with Down syndrome;American Journal of Medical Genetics Part C: Seminars in Medical Genetics;2024-07-05

2. Circulating biomarkers of inflammaging and Alzheimer’s disease to track age-related trajectories of dementia: Can we develop a clinically relevant composite combination?;Ageing Research Reviews;2024-04

3. From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-04

4. Altered peripheral blood leukocyte subpopulations, function, and gene expression in children with Down syndrome: implications for respiratory tract infection;European Journal of Medical Genetics;2024-04

5. Label-free detection of Aβ-42: a liquid crystal droplet approach for Alzheimer's disease diagnosis;RSC Advances;2024